CL King Downgrades Minerals Technologies to Neutral

CL King analyst David Silver downgrades Minerals Technologies (NYSE:MTX) from Buy to Neutral.

byBenzinga Newsdesk

August 30, 2022

1 minute read

CL King analyst David Silver downgrades Minerals Technologies (NYSE:MTX) from Buy to Neutral.

As Post-Modern As It Gets: You Can Now Get Mushroom-Infused Edibles Delivered At Home In All-Electric Vehicles

By Javier Hasse

Today, 5:33 AM

Hyphae Wellness, a mushroom company based in Eugene, Oregon, has partnered with Arcimoto (NASDAQ: FUV) to create a home delivery service where mushroom products are delivered in an all-electric vehicle.

FUV

Barclays Downgrades Southwest Airlines to Equal-Weight, Lowers Price Target to $38

By Benzinga Newsdesk

Today, 5:33 AM

Barclays analyst Brandon Oglenski downgrades Southwest Airlines (NYSE:LUV) from Overweight to Equal-Weight and lowers the price target from $42 to $38.

LUV

FDA
News

‘Israel finds Pfizer’s COVID vaccine booster improves protection for elderly’ -New York Post Report

By Benzinga Newsdesk

Today, 5:33 AM

https://nypost.com/2021/08/23/pfizers-covid-booster-improves-protection-israel-study-shows/?utm_source=twitter_sitebuttons&utm_medium=site%20buttons&utm_campaign=site%20buttons

BNTX

Accelerate Diagnostics Announces Proposed Public Offering of Common Stock, No Terms Disclosed

By Michael Horton

Today, 5:33 AM

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) ("Accelerate Diagnostics") today announced that it has commenced an underwritten public offering of shares of its common stock. Accelerate Diagnostics expects to grant

AXDX

CL King Downgrades Minerals Technologies to Neutral

Related Posts

As Post-Modern As It Gets: You Can Now Get Mushroom-Infused Edibles Delivered At Home In All-Electric Vehicles

Barclays Downgrades Southwest Airlines to Equal-Weight, Lowers Price Target to $38

‘Israel finds Pfizer’s COVID vaccine booster improves protection for elderly’ -New York Post Report

Accelerate Diagnostics Announces Proposed Public Offering of Common Stock, No Terms Disclosed